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Key points
 Rett syndrome is a prototypical neurological disorder characterised by abnormal breathing
pattern and reduced ventilatory CO2 sensitivity. Medullary astrocytes are a crucial component
of central CO2/pH chemosensitivity.
 This study tested the hypotheses that methyl-CpG-binding protein 2 (MeCP2) deficient
medullary astrocytes are (i) unable to produce/release appropriate amounts of lactate, and/or
(ii) unable to sense changes in PCO2/[H
+].
 We found no differences in tonic or hypoxia-induced release of lactate from the ventral surface
of the medulla oblongata or cerebral cortex between MeCP2-knockout and wild-type mice.
 Respiratory acidosis triggered robust [Ca2+]i responses in wild-type astrocytes residing near
the ventral surface of the medulla oblongata. CO2-induced [Ca2+]i responses in astrocytes
were dramatically reduced in conditions of MeCP2 deficiency.
 These data suggest that (i) ‘metabolic’ function of astrocytes in releasing lactate into the
extracellular space is not affected by MeCP2 deficiency, and (ii) MeCP2 deficiency impairs the
ability of medullary astrocytes to sense changes in PCO2/[H
+].
Abstract Rett syndrome, a prototypical neurological disorder caused by loss of function of
the transcriptional regulator methyl-CpG-binding protein 2 (MeCP2) gene, is associated with a
severely disordered breathing pattern and reduced ventilatory CO2 sensitivity. In a mouse model
of Rett syndrome (MeCP2 knockout), re-introduction of theMeCP2 gene selectively in astrocytes
rescues normal respiratory phenotype. In the present study we determined whether themetabolic
and/or signalling functions of astrocytes are affected by testing the hypotheses that in conditions
of MeCP2 deficiency, medullary astrocytes are unable to produce/release appropriate amounts
of lactate or detect changes in PCO2/[H
+], or both. No differences in tonic or hypoxia-induced
release of lactate from the ventral surface of the medulla oblongata or cerebral cortex in brain
slices ofMeCP2-knockout and wild-type mice were found. In brainstem slices of wild-type mice,
respiratory acidosis triggered robust elevations in [Ca2+]i in astrocytes residing near the ventral
surface of themedulla oblongata. Themagnitude of CO2-induced [Ca2+]i responses inmedullary
astrocytes was markedly reduced in conditions of MeCP2 deficiency, whereas [Ca2+]i responses
to ATP were unaffected. These data suggest that (i) metabolic function of astrocytes in releasing
lactate into the extracellular space is not affected byMeCP2 deficiency, and (ii) MeCP2 deficiency
impairs the ability of medullary astrocytes to sense changes in PCO2/[H
+]. Taken together with
the evidence of severely blunted ventilatory sensitivity to CO2 in mice with conditional MeCP2
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deletion in astroglia, these data support the hypothesis of an important role played by astrocytes
in central respiratory CO2/pH chemosensitivity.
(Received 19 February 2015; accepted after revision 11 May 2015; first published online 15 May 2015)
Corresponding author A. V. Gourine: Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuro-
science, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, UK. Email:
a.gourine@ucl.ac.uk
Abbreviations aCSF, artificial cerebrospinal fluid; BDNF, brain-derived neurotrophic factor; CSF, cerebrospinal fluid;
KO, knockout;MeCP2,methyl-CpG-binding protein 2; OGB,OregonGreen-488 BAPTA-1AM; SR101, sulforhodamine
101; TRPC, transient receptor potential channels; WT, wild-type.
Introduction
Astrocytes provide neurones with structural and
metabolic support. They are well positioned to respond
rapidly to changes in chemical composition of the
blood supplying the brain as well as to sense metabolic
demands of the neuronal networks acting as an essential
cellular component of the neurovascular interface. The
astrocyte–neurone lactate shuttle hypothesis proposes that
astrocytes support neuronal activity by supplying neuro-
nal networks with metabolic substrate in the form of
lactate (Magistretti et al. 1993, 1994; Pellerin&Magistretti,
1994). In lowPO2 conditions (hypoxia), lactate production
by astrocytes increases and appears to be essential for
the recovery of synaptic function during re-oxygenation
(Schurr et al. 1997a,b,c). Recent evidence suggests that
astrocytes play an important role in the central nervous
mechanisms controlling breathing. Astrocytes residing at
and near the ventral surface of the medulla oblongata
are intrinsically sensitive to changes in parenchymal
PCO2/[H
+] and during hypercapnia contribute to the
adaptive increases in breathing (Gourine et al. 2010).
Mutations in the human transcriptional regulator
methyl-CpG-binding protein 2 (MeCP2) gene leading
to loss or reduction of protein function cause a neuro-
developmental disorder called Rett syndrome (Amir et al.
1999). Severely arrhythmic breathing which includes
frequent apnoeas, hypopneas and periods of hyper-
ventilation is a hallmark of this prototypical neurological
disorder (Southall et al. 1988; Viemari et al. 2005; Ramirez
et al. 2013). The respiratory dysrhythmia often results in
hypoxaemia and hypocapnia (De Felice et al. 2014). In
animal (mouse) models, MeCP2 deficiency is associated
with significantly depressed ventilatory sensitivity to
CO2, especially in response to mild and moderate levels
of hypercapnia (Zhang et al. 2011; Bissonnette et al.
2014). MeCP2 deficiency also significantly increases the
CO2 apnoeic threshold (Toward et al. 2013). Conversely,
ventilatory responses to hypoxia appear to be enhanced
(Bissonnette & Knopp, 2006; Voituron et al. 2009;
Bissonnette et al. 2014), while a higher level of inspired
oxygen worsens the occurrence of periodic breathing
in mice with reduced MeCP2 function (Bissonnette &
Knopp, 2008). Interestingly, in the affected individuals
and animal models, regularity of breathing is improved by
supplemental CO2 provided in the inspiratory gasmixture
(Smeets et al. 2006; Bissonnette & Knopp, 2008).
MeCP2 is expressed in astrocytes (Yasui et al. 2013;
Forbes-Lorman et al. 2014) and loss of MeCP2 function
causes critical astrocytic defects (Okabe et al. 2012). There
are in vitro data showing that the function of wild-type
neurones is compromised when they are co-cultured
with MeCP2-deficient astrocytes (Ballas et al. 2009;
Maezawa et al. 2009;Maezawa& Jin, 2010). Earlier reports
highlighted the importance of astroglial dysfunction in
the development of Rett syndrome and demonstrated that
re-expression of MeCP2 selectively in astrocytes rescues
normal respiratory pattern inMeCP2 deficient mice (Lioy
et al. 2011). Since astrocytes located at and near the ventral
surface of themedulla oblongata contribute in a significant
manner to the mechanisms of central respiratory CO2
chemosensitivity, we proposed that impaired astroglial
CO2 sensitivity could underlie the respiratory phenotype
observed in Rett syndrome.
In this studywefirst determinedwhether the ‘metabolic’
function of astrocytes is compromised by MeCP2
deficiency by measuring the amount of lactate released
by the brain slices of MeCP2-null and wild-type male
mice. Then we determined whether Ca2+ signalling and
CO2/pH sensitivity of medullary astrocytes are affected in
the absence of MeCP2 function.
Methods
All the experimentswereperformed inaccordancewith the
European Commission Directive 2010/63/EU (European
Convention for the Protection of Vertebrate Animals used
for Experimental and Other Scientific Purposes) and the
UK Animals (Scientific Procedures) Act (1986).
MeCP2-null mice
In total 28 MeCP2-null and 26 littermate wild-type
male mice (65–80 days old) were used for the
experiments. MeCP2 is an X-linked gene subject to
random X inactivation (Braunschweig et al. 2004) and
MeCP2 mutant heterozygous females show mosaicism.
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Since phenotype depends on both cell-autonomous
and non-cell-autonomous mechanisms (Braunschweig
et al. 2004), only male mice were used in the
current study. We used two MeCP2-null strains:
B6.129P2(C)-MeCP2tm1.1Bird/J (Bird, n = 26) as a model
of a complete MeCP2 knockout (Guy et al. 2001), and
MeCP2tm1.1Jtc/SchvJ (Coyle, n = 2), which carries one
of the most common mutations that affect humans
where a non-functional truncated MeCP2 protein trans-
cript is present (Lawson-Yuen et al. 2007). The former
was maintained on a C57BL/6J background and the
latter on a mixed background 87–93% C57BL/6J
and 13–6% 129S6/SvEvTac. Null males were obtained
from breeding heterozygous females to wild-type males.
Heterozygous MeCP2tm1.1Bird females were obtained from
The Jackson Laboratory (Bar Harbor, Maine, USA). Their
offspringwere genotyped using standard PCR, and primer
sequences were as follows: common (AAA TTGGGTTAC
ACC GCT GA), mutant reverse (CCA CCT AGC CTG
CCT GTA CT) and wild-type reverse (CTG TAT CCT
TGG GTC AAG CTG). Heterozygous MeCP2tm1.1Jtc were
donated byDr Laura R. Schaevitz (Tufts University). Their
offspring were genotyped using Sanger sequencing, and
primer sequences were as follows: MeCP2 forward (AGG
TGG GAG ACA CCT CCT TG) andMeCP2 reverse (GAC
CTG GGC AGA TGT GGT AG).
Slice preparation
Mice were terminally anaesthetised with a halothane
inhalation overdose. The brains were removed and placed
in ice cold artificial cerebrospinal fluid (aCSF) containing
124 mM NaCl, 26 mM NaHCO3, 3 mM KCl, 2 mM
CaCl2, 1.25 mM NaH2PO4, 1 mM MgSO4, 10 mM glucose,
saturatedwith 95%O2–5%CO2 (pH7.4)with an addition
of 9 mM Mg2+. Horizontal brainstem slices containing
the ventral surface of the medulla oblongata (thickness
300 µm; the pia mater was kept intact and undisturbed
during slicing) or coronal brainstem and cortical slices
(thickness 250 µm) were cut using a vibrating-blade
microtome and then incubated at room temperature for
1 h in a standard aCSF saturated with 95% O2–5% CO2.
Biosensor recordings
Lactate release was measured using amperometric lactate
biosensors (Sarissa Biomedical, Coventry, UK) placed
in direct contact with the surface of the slice. A
lactate biosensor uses lactate oxidase that in the pre-
sence of oxygen converts lactate to pyruvate and H2O2
(which is detected electrochemically). A dual recording
configuration of a null sensor (lacking lactate oxidase)
placed in an equivalent position along the lactate
biosensor was used (Fig. 1A). The null sensor serves as
a control to determine whether any non-specific electro-
active interferents were released and confounded the
measurements. Null sensor currents were subtracted from
the lactate biosensor currents. Biosensors were calibrated
with 100 µM lactate before and after the recordings
(Fig. 1A). To convert changes in sensor current to changes
in lactate concentration, the means of the initial and
final calibrations were used. Recordings were made from
Figure 1. Tonic and hypoxia-induced release of lactate by the brainstem and cerebral cortex are not
affected in conditions of MeCP2 deficiency
A, representative example of changes in lactate biosensor current during calibration by application of L-lactate
(100 µM), after biosensor placement in direct contact with the surface of the brainstem slice (revealing lactate
tone), and in response to a hypoxic challenge (perfusion with aCSF saturated with 95% N2–5% CO2). Peak
hypoxia-induced lactate release is measured upon re-oxygenation. Inset: schematic drawing of a horizontal brain-
stem slice illustrating dual recording configuration of lactate and null (control) biosensors placed on the ventral
medullary surface. Difference in current between lactate and null biosensors was used to determine the amount of
lactate release. py, pyramidal tract; XII hypoglossal rootlets; B, summary data showing tonic and hypoxia-induced
release of lactatemeasured at the surface of the horizontal brainstem and coronal cortical slices ofMeCP2-knockout
(KO) and wild-type (WT) mice. Numbers in parentheses indicate sample sizes.
C© 2015 The Authors The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
3162 E. Turovsky and others J Physiol 593.14
the slice placed on an elevated grid in a flow chamber
at 35°C. Hypoxic conditions were induced for 2 min
by replacement of oxygen in the medium with nitrogen
(perfusion of the chamber with aCSF saturated with
95% N2 and 5% CO2). Since the lactate biosensor
requires oxygen to operate, decreases in O2 concentration
reduce biosensor currents (Fig. 1A). Therefore, peak
lactate release induced by hypoxia was determined upon
re-oxygenation (Fig. 1A).
Calcium imaging
Optical measurements of changes in [Ca2+]i in brain-
stemastrocyteswere performedusing anuprightOlympus
FV1000 microscope (Olympus, Japan), equipped with
25× and 40× water immersion objectives. Regions
for imaging were selected based on the distance from
the pyramidal tracts, the boundary of the pons and
the edge of the slice, targeting cells residing near the
surface of the brainstem in locations corresponding
to the chemosensitive retrotrapezoid nucleus of the
rostroventrolateral medulla oblongata. [Ca2+]i responses
were visualised using a conventional Ca2+ indicator,
Oregon Green-488 BAPTA-1, AM (OGB-1). Slices were
incubated for 60 min at room temperature in 95 O2–5%
CO2-saturated aCSF containing OGB-1 (10 µM) followed
by 15 min incubation with sulforhodamine 101 (SR101,
30 µM) to aid identification of astroglial cells. Then,
slices were washed for 15 min at room temperature in
aCSF (saturated with 95% O2–5% CO2) for complete
esterification of OGB-1. Imaging of Ca2+ responses was
performed from the slice placed on an elevated grid in
a flow chamber (volume 2 ml) at 35°C. The rate of
perfusionwas 4mlmin−1. The 488 nmargon laser linewas
used to excite OGB-1 fluorescence, which was measured
using a bandpass filter of 505–550 nm. Illumination
intensity was kept to a minimum (at 0.5–0.7% of laser
output). SR101 fluorescence was excited at 514 nm, and
emitted fluorescence at 641–716 nmwas recorded. Hyper-
capnic conditions (respiratory acidosis) were induced by
perfusion of the chamber with aCSF saturated with 90%
O2–10% CO2. Fluorescence intensities in the regions of
interest (ROIs) corresponding to astroglial somas were
measured and background level was subtracted. On
average responses of 10 labelled cells per slice were
captured and analysed.
Data analysis
Lactate biosensor measurements were processed using
a 1401 interface and analysed using Spike2 software
(Cambridge Electronic Design Ltd, Cambridge, UK).
Built-inOlympus analysis softwarewas used to analyse the
results of the imaging experiments. Data are reported as
means ± SEM. Datasets were compared using Wilcoxon’s
signed rank test or Student’s t test for paired or unpaired
data, as appropriate. Differences between groups with P
values of less than 0.05 were considered to be significant.
Results
Astrocytes are the only type of brain cell that store
glycogen, and according to the evidence supporting
the ‘lactate shuttle hypothesis’ produce and release
lactate into the extracellular space to be taken up by
neighbouring neurones (Pellerin & Magistretti, 1994).
We first thought to determine whether the ‘metabolic’
function of astrocytes is compromised in conditions of
MeCP2 deficiency by measuring the amount of lactate
released by the brainstem slices of MeCP2-null and
wild-typemice. For comparison, lactate release by cortical
slices was also evaluated in order to determine whether
MeCP2 deficiency is associated with global inability of
astrocytes to release an appropriate amount of lactate.
Tonic lactate release (lactate tone) was detected when
lactate biosensors were placed in direct contact with the
uncut ventral surface of the brainstem (Fig. 1A) or coronal
cortical slices of theMeCP2-null mice and their wild-type
counterparts. No differences in the amount of lactate
released by the brainstem slices were observed between
preparations of the MeCP2-knockout (301 ± 27 µM,
n = 19) and wild-type (310 ± 18 µM; n = 21) mice.
Facilitated release of lactate in response to hypoxia
was assessed in eight brainstem slice preparations of
MeCP2-knockout and eight brainstem slice preparations
ofwild-typemice aswell as in six cortical slice preparations
ofMeCP2-knockout and five cortical slice preparations of
wild-type mice. No significant differences in the amount
of lactate released in response to the hypoxic challenge
were observed between brainstem and cortical slices of
MeCP2-knockout and wild-type mice (Fig. 1B).
Astrocytes which reside near the ventral surface of the
medulla oblongata display [Ca2+]i responses to chemo-
sensory challenges and release gliotransmitters (pre-
dominantly ATP) which excite neurones of the brainstem
respiratory network contributing to the adaptive increases
in central respiratory drive (Gourine et al. 2010). We
next determinedwhetherCO2/pH sensitivity ofmedullary
astrocytes is affected by MeCP2 deficiency.
Efficacy of SR101 labelling of brainstem astroglia
was previously reported to be low (Schnell et al.
2012). Therefore, chemosensitive astrocytes of the ventral
medulla oblongata were identified using several criteria:
(i) labelling with SR101 (Fig. 2A); (ii) Ca2+ response
to hypercapnia (Fig. 2B); (iii) lack of Ca2+ response to
application of KCl (Fig. 2B); and (iv) Ca2+ response
to application of ATP (Fig. 2B). In wild-type mice,
respiratory acidosis (perfusion of the recording chamber
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with aCSF saturated with 90% O2–10% CO2) triggered
robust elevations in [Ca2+]i in astrocytes residing near
the ventral surface of the medulla oblongata (Figs 3A and
4A). The magnitude of CO2-induced [Ca2+]i responses
in ventral medullary astrocytes was markedly reduced
in conditions of MeCP2 deficiency (Figs 3B and 4A).
CO2-induced [Ca2+]i responses were equally suppressed
inmedullary astrocytes of both strainsofMeCP2-nullmice
(Bird and Coyle, Fig. 3B). Ca2+ responses triggered by
application of exogenous ATP were not affected (Fig. 3B,
left panel).
In astrocytes recorded in slice preparations of
MeCP2-knockout animals which failed to respond
to a standard chemosensory challenge (10% CO2),
[Ca2+]i responses were triggered when severe hyper-
capnia/acidosis was applied (Fig. 3B, right panel). These
data demonstrate that MeCP2 deficiency reduces the
ability of medullary astrocytes to sense changes in
PCO2/[H
+]. Preserved Ca2+ responses to activation of ATP
receptors suggests that the mechanisms underlying Ca2+
recruitment from the intracellular stores and/or Ca2+
entry are not affected by MeCP2 deficiency.
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Figure 2. Chemosensitive astrocytes of the ventral medulla
oblongata in mice
A, putative astrocytes residing near the ventral surface of the
medulla oblongata loaded with Ca2+ indicator Oregon Green-488
BAPTA-1, AM (OGB) and identified by labelling with sulforhodamine
101 (SR101). Scale bar, 25 µm; B, CO2/pH-sensitive astrocytes of the
ventral medulla oblongata of a wild-type mouse identified by a
[Ca2+]i response to the respiratory acidosis (perfusion of the
chamber with aCSF saturated with 90% O2–10% CO2), lack of
Ca2+ response to application of KCl, and Ca2+ response to
application of ATP.
Discussion
Rett syndrome – a prototypical neurological disorder
caused byMeCP2 deficiency – is associated with a severely
disordered breathing pattern (Southall et al. 1988; Julu
et al. 2001; Weese-Mayer et al. 2006; De Felice et al.
2014) and reduced ventilatory CO2 sensitivity (Zhang
et al. 2011; Bissonnette et al. 2014). In a mouse model of
Rett syndrome (MeCP2 gene knockout), re-introduction
of theMeCP2 gene selectively in astrocytes rescues normal
respiratory phenotype (Lioy et al. 2011), suggesting that
astroglial dysfunction underlies the development of the
disease.Moreover, inmice selective and inducible deletion
of MeCP2 in astrocytes leads to a dramatically reduced
ventilatory sensitivity to CO2 (Bissonnette et al. 2012),
indicating that the respiratory neural circuits, including
putative central chemosensitive neurones, are unable to
generate appropriateCO2-sensitive respiratorydrivewhen
astrocytes are devoid of MeCP2. These data support
the hypothesis of a key role played by astrocytes in the
mechanisms of central CO2 chemosensitivity (Gourine
et al. 2010).However, themechanisms underlying reduced
ventilatory CO2 sensitivity in conditions of MeCP2
deficiency are not known. Since astrocytes provide neural
circuits with structural and metabolic support (metabolic
function) and also have a signalling role, it remains
unclear which of these two key astroglial functions is
affected.
In the present study we found no differences in
tonic and hypoxia-induced release of lactate measured
from the ventral surface of the medulla oblongata or
cerebral cortex in brain slices of MeCP2-knockout and
wild-type mice. However, Ca2+ responses of ventral
medullary astrocytes ofMeCP2-knockout animals evoked
by standard experimental chemosensory challenge (10%
CO2) were dramatically reduced, while Ca2+ elevations
induced by application of the exogenous ATP were pre-
served. In conditions of MeCP2 deficiency, robust Ca2+
responses in medullary astrocytes were only elicited when
severe chemosensory challenge (>20% CO2) was applied.
Preserved lactate tone and unaltered release of lactate
in low oxygen conditions in preparations of MeCP2-null
mice suggest that metabolic function of astrocytes in
providing neurones with the energy substrate in the form
of lactate is not affected in the absence ofMeCP2 function.
This is somewhat surprising considering the variety of
astroglial gene pathways controlled by this nuclear protein
(Yasui et al. 2013; Forbes-Lorman et al. 2014). The ability
of MeCP2 deficient brain tissue to release an appropriate
amount of lactate might be an important factor in
preventing or delaying widespread neuronal death and
allowing recovery of synaptic function after acute tissue
hypoxia (Schurr et al. 1997a,c,b), despite significant
oxidative stress associatedwith recurrent episodes of inter-
mittent hypoxia (De Felice et al. 2012, 2014). Indeed, it is
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not uncommon for Rett syndrome patients to experience
episodes of severe oxygen desaturation (SPO2  80%)
(Andaku et al. 2005; Hagebeuk et al. 2012; Carotenuto
et al. 2013), yet post-mortem reports revealed no evidence
of widespread neuronal degeneration (Cornford et al.
1994; Armstrong, 1995; Bauman et al. 1995). This is
also supported by the evidence demonstrating that acute
re-expression of MeCP2 in adult knockout mice rescues
the overt neurological phenotype, indicating that MeCP2
deficiency is associated with limited neurodegeneration
(Guy et al. 2007). Interestingly, in patients with Rett
syndrome, elevated cerebrospinal fluid (CSF) level of
lactate positively correlates with respiratory dysfunction
but not with other neurological features (Matsuishi et al.
1992, 1994; Lappalainen & Riikonen, 1994). The data
reported here suggest that the high levels of lactate in the
CSF of patients with Rett syndrome may reflect enhanced
astroglial release in response to recurrent episodesof hypo-
xia that inevitably accompany the disordered breathing
pattern associated with this condition (the significance
A
B
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10% CO2 23% CO2
10% CO2 ATP 30µM
50 s
50 s
50 s 50 s
Figure 3. CO2-chemosensitivity of
medullary astrocytes is compromised
in conditions of MeCP2 deficiency
A, representative examples of CO2-evoked
[Ca2+]i responses in astrocytes recorded in
brainstem slice preparations of two
individual wild-type (WT) mice; B,
representative examples of CO2-evoked
[Ca2+]i responses in astrocytes recorded in
brainstem slice preparations of Bird (left)
and Coyle (right) strains of MeCP2-
knockout (KO) mice.
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Figure 4. Summary data illustrating the effect of MeCP2 deficiency on CO2-induced Ca2+ responses of
ventral medullary astrocytes
A, time course of [Ca2+]i changes induced by respiratory acidosis (perfusion of the chamber with aCSF saturated
with 90% O2–10% CO2) in astrocytes recorded in brainstem slices of MeCP2-knockout (KO) mice and their
wild-type (WT) counterparts; B, summary data of basal OGB fluorescence and peak CO2-induced increases in
OGB fluorescence in astrocytes recorded in brainstem slices of MeCP2-knockout and wild-type mice. Values
of n indicate the numbers of CO2-sensitive astrocytes recorded in 8 knockout and 8 wild-type brainstem slice
preparations. ∗∗Significant difference in peak CO2-evoked response between wild-type and MeCP2-knockout
astrocytes (P < 0.01). ∗∗∗Significant difference in OGB fluorescence at the peak of the ATP-induced response
compared to the baseline (P < 0.001).
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of high CSF lactate in Rett patients in the context of the
findings obtained in the present study is discussed below).
The results of the present study also show that MeCP2
deficiency dramatically reduced the ability of brainstem
astrocytes to sense changes in PCO2/[H
+]. Astrocytes are
not electrically excitable and their signalling function is
governedby changes in intracellular [Ca2+].Wepreviously
demonstrated high sensitivity of medullary astrocytes
to physiological changes in pH (Gourine et al. 2010).
Astrocytes respond to hypercapnia/acidosis with robust
elevations in [Ca2+]i, leading to the release of ATP,
which propagates astrocytic activation and excites neuro-
nes of the brainstem respiratory network, contributing
to the adaptive increases in central respiratory drive
(Gourine et al. 2005, 2010; Kasymov et al. 2013). Astroglial
CO2/pH sensitivity has been incorporated in the current
models of brain respiratory chemosensitivity, centred on
a group of highly pH sensitive neurones of the medullary
retrotrapezoid nucleus (RTN), which are proposed to play
the most significant role, with neighbouring astrocytes
providing an additional 20–30% of the chemosensory
drive to breathe (Guyenet, 2014).
This study contributes to the body of evidence
suggesting that the role of astrocytes in the central nervous
mechanisms linking changes in brain parenchymal
PCO2/[H
+] and central respiratory drive is greater thanwas
previously appreciated. First, sensitivity of RTN neurones
to changes in pH (as assessed in the organotypic brainstem
slice preparation) is, to a large extent, mediated by prior
release of gliotransmitter(s), primarily ATP (Gourine
et al. 2010). Other experiments conducted in acute slices
estimated that ATP actions contribute some 30% to
the overall response of RTN neurones to respiratory
acidosis (Wenker et al. 2012). Second, specific genetic
targeting and silencing of RTN neurones reduces phrenic
nerve response to systemic hypercapnia in vivo by 30%
(Marina et al. 2010) – the effect similar in magnitude
to that observed following blockade of ATP receptors
within the region (Gourine et al. 2005; Wenker et al.
2012). Third, in mice astrocyte-specific inducible deletion
of MeCP2 results in a dramatically reduced ventilatory
sensitivity to CO2 (Bissonnette et al. 2012), the effect
being similar to that observed in animals with global
MeCP2 deficiency (Zhang et al. 2011; Bissonnette et al.
2014). If astrocytes contribute only a small fraction of the
overall respiratory response to systemic hypercapnia, then
intact functional chemosensitive RTN neurones would be
expected to mount an appropriate ventilatory response
regardless of astroglial involvement (especially when we
consider that themetabolic function of astrocytes does not
appear to be affected by MeCP2 deficiency). Finally, the
data reported here demonstrate that astroglial sensitivity
to changes in PCO2/[H
+] is dramatically reduced in
the absence of MeCP2, the effect being consistent with
associated respiratory phenotype and the hypothesis of a
prominent role played by astroglia in the mechanisms of
central respiratory CO2 chemosensitivity. It was possible
to trigger [Ca2+]i responses inMeCP2-deficient astrocytes
by application of a severe hypercapnic stimulus (>20%
CO2) suggesting a shift in sensitivity, although we did
not investigate this systematically. Interestingly, shift in
ventilatory CO2 sensitivity has also been demonstrated in
MeCP2-null mice (Zhang et al. 2011; Toward et al. 2013;
Bissonnette et al. 2014).
The mechanisms of intracellular Ca2+ recruitment
evoked by activation of purinoceptors do not appear
to be affected, as the responses to the exogenously
applied ATP were preserved in astrocytes of MeCP2-null
mice. These data suggest that reduced CO2 sensitivity
in conditions of MeCP2 deficiency is upstream from
astroglial release of ATP (which under normal conditions
propagates Ca2+ excitation among ventral medullary
astrocytes; Gourine et al. 2010).However, themechanisms
of CO2/pH sensitivity of astrocytes remain unknown.
A number of putative mechanisms have been proposed
including involvement of (i) certain ion channels (e.g. pH
sensitive inward rectifier K+ channels – Kirs) (Mulkey &
Wenker, 2011), (ii) a molecular CO2 sensor (e.g. connexin
26) (Huckstepp et al. 2010a,b), and (iii) an electrogenic
Na+/HCO3− cotransporter (Mulkey & Wenker, 2011).
Of these mechanisms MeCP2 deficiency has been
shown to alter expression of the pH sensitive Kir4.1
channels in the locus coeruleus (Zhang et al. 2011) –
one of the functional respiratory CO2 chemosensitive
brainstem areas. It was suggested that overexpressed
Kir4.1 subunit may favour formation of homomeric
Kir4.1 channels, which are less sensitive to changes in
pH than heteromeric Kir4.1–Kir5.1 (Zhang et al. 2011).
Kir4.1–Kir5.1 heteromeric channels are expressed by
astrocytes and have been proposed by some studies to
underlie astrocyticCO2/pHsensitivity (Wenker et al.2010;
Mulkey &Wenker, 2011). Signallingmolecules released by
activated astrocytes (ATP and lactate) have a significant
impact on the activity of locus coeruleus neurones (Harms
et al. 1992; Tang et al. 2014), suggesting that reduced
chemosensory responses of these neurones in conditions
of MeCP2 deficiency (Zhang et al. 2011) may also be
secondary to impaired CO2 sensitivity of local astrocytes.
Indeed, in astrocytes Kir4.1 expression is regulated by
DNAmethylation throughout development, and therefore
MeCP2 deficiency may lead to Kir4.1 overexpression
(Nwaobi et al. 2014). However, more recent studies
demonstrated that Kir4.1 expression is reduced in cortical
astrocytes of heterozygous MeCP2 deficient female mice
(Cuddapah et al. 2013) and the earlier evidence argues
against any significant role of Kir4.1–Kir5.1 heteromeric
channels in themechanisms of central respiratory chemo-
sensitivity (Trapp et al. 2011).
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One potential mechanism which may underlie reduced
CO2 sensitivity of MeCP2 deficient astrocytes may be
related to the disruption of brain-derived neurotrophic
factor (BDNF)-mediated signalling (Amaral et al. 2007).
MeCP2 is an important regulator of BDNF transcription
(Chen et al. 2003;Martinowich et al. 2003). BDNF protein
levels are reduced in conditions of MeCP2 deficiency
(Chang et al. 2006; Wang et al. 2006), while stimulation of
BDNF receptors improves respiratory pattern in MePC2
null mice (Schmid et al. 2012; Kron et al. 2014). Part of the
BDNF signalling pathway involves activation of certain
transient receptor potential channels (TRPCs) (Amaral
et al. 2007). Noteworthy is a recently described TRPA1
channel that plays an important role in generation of
Ca2+ transients in astrocytes (Shigetomi et al. 2013).
Together, these pieces of evidence suggest that disruption
of BDNF- and TRPC-mediated Ca2+ homeostasis and
signalling in astrocytes may underlie reduced Ca2+
responses to CO2 in medullary astrocytes of MeCP2-null
mice.
The combination of preserved tonic and hypoxia-
induced lactate release and markedly reduced CO2
sensitivity of medullary astrocytes could underlie seve-
rely disordered breathing observed in Rett syndrome.
Cheyne–Stokes-like breathing pattern characterised by
recurrent central apnoeas followed by periods of hyper-
ventilation is frequent inRett syndromepatients (Julu et al.
2001) and is also observed in mouse models (Bissonnette
& Knopp, 2008; Abdala et al. 2010). Recurrent apnoeas
followedbyperiods of hyperventilation are associatedwith
chronic hypoxaemia and hypocapnia, as O2 saturation
does not fully recover from apnoeas, and hyperventilation
washes out CO2 (De Felice et al. 2014). Our data suggest
that the acute bouts of severe hypoxaemia and hyper-
ventilation would lead to the increased levels of brain
lactate, as was demonstrated by measurements of high
CSF lactate in Rett syndrome patients (Matsuishi et al.
1992, 1994; Lappalainen & Riikonen, 1994). This, in
turn,would contribute tobrainparenchymal acidification,
whichwould facilitate hyperventilation,washing outmore
CO2. Increased CO2 apnoeic threshold and reduced CO2
sensitivity would favour prolonged apnoeas.
In summary, the data obtained in the present study
suggest that MeCP2 deficiency is associated with a
dramatically reduced sensitivity ofmedullary astrocytes to
changes in PCO2/[H
+]. Metabolic function of astrocytes in
providing neurones with readily available metabolic sub-
strate in the form of lactate does not appear to be affected.
Taken together with the evidence of a severely blunted
ventilatory response to CO2 in conditions of inducible
deletion of MeCP2 specifically in astrocytes (Bissonnette
et al. 2012), these data support the hypothesis of an
important role played by astroglia in the mechanisms of
central respiratory CO2/pH chemosensitivity.
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